| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00002371-200301000-00006 |
| P698 | PubMed publication ID | 12514429 |
| P50 | author | Pinku Mukherjee | Q109981231 |
| P2093 | author name string | Sandra J Gendler | |
| Babita Agrawal | |||
| Joanne Parker | |||
| Fred Jacobs | |||
| Cathy S Madsen | |||
| Teresa L Tinder | |||
| B Michael Longenecker | |||
| Amelia R Ginardi | |||
| P433 | issue | 1 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 47-62 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Journal of Immunotherapy | Q15763946 |
| P1476 | title | Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer | |
| P478 | volume | 26 |
| Q36648430 | An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells |
| Q39658273 | Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model |
| Q37221915 | Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors |
| Q36718256 | Antigen choice determines vaccine-induced generation of immunogenic versus tolerogenic dendritic cells that are marked by differential expression of pancreatic enzymes |
| Q36903442 | Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling |
| Q37360215 | Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis |
| Q36625526 | Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas |
| Q34000467 | Collagen induced arthritis increases secondary metastasis in MMTV-PyV MT mouse model of mammary cancer |
| Q64078973 | Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma |
| Q37071139 | Comparison of cytotoxic T lymphocyte responses against pancreatic cancer induced by dendritic cells transfected with total tumor RNA and fusion hybrided with tumor cell |
| Q50225593 | Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway |
| Q34121591 | Differential induction of innate immune responses by synthetic lipid a derivatives |
| Q47126640 | Electrochemical and optical biosensors for early-stage cancer diagnosis by using graphene and graphene oxide. |
| Q36190339 | Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue |
| Q39467521 | Human dendritic cells transfected with amplified MUC1 mRNA stimulate cytotoxic T lymphocyte responses against pancreatic cancer in vitro |
| Q33961477 | Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist |
| Q35657628 | Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine |
| Q50908486 | Immunization with a Synthetic Human MUC1 Glycopeptide Vaccine against Tumor-Associated MUC1 Breaks Tolerance in Human MUC1 Transgenic Mice. |
| Q73417017 | Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells |
| Q37662390 | Induction of invasive transitional cell bladder carcinoma in immune intact human MUC1 transgenic mice: a model for immunotherapy development |
| Q34565145 | Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization |
| Q35000523 | Lessons in signaling and tumorigenesis from polyomavirus middle T antigen |
| Q35898801 | MUC1 Vaccines, Comprised of Glycosylated or Non-Glycosylated Peptides or Tumor-Derived MUC1, Can Circumvent Immunoediting to Control Tumor Growth in MUC1 Transgenic Mice. |
| Q37059144 | MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma |
| Q37737313 | MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy |
| Q40197046 | MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model |
| Q34661793 | Mechanisms of malignant glioma immune resistance and sources of immunosuppression |
| Q55322543 | Mucin architecture behind the immune response: design, evaluation and conformational analysis of an antitumor vaccine derived from an unnatural MUC1 fragment. |
| Q47759359 | Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model |
| Q34107518 | Over-expression of ST3Gal-I promotes mammary tumorigenesis |
| Q37384753 | Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity |
| Q44976246 | Recombinant plant-expressed tumour-associated MUC1 peptide is immunogenic and capable of breaking tolerance in MUC1.Tg mice. |
| Q37259594 | Strategies used for MUC1 immunotherapy: preclinical studies |
| Q35133083 | Systemic neutralization of IL-17A significantly reduces breast cancer associated metastasis in arthritic mice by reducing CXCL12/SDF-1 expression in the metastatic niches |
| Q42171605 | Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis |
| Q35886761 | Tecemotide: an antigen-specific cancer immunotherapy |
| Q39802340 | The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours |
| Q46610438 | Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention |
| Q109981231 | Pinku Mukherjee | contributed to creative work | P3919 |
Search more.